Sfoglia per AUTORE
KAISER R
Collezione AOU San Luigi di Orbassano
Items : 3
Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2023 May;179:107173. doi: 10.1016/j.lungcan.2023.03.009. Epub 2023 Mar 15.
2023
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Reck M; Popat S; Grohé C; Corral J; Novello S; Gottfried M; Brueckl W; Radonjic D; Kaiser R; Heymach J;
Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer? in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jun;144:76-84. doi: 10.1016/j.lungcan.2020.04.009. Epub 2020 Apr 20.
2020
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Radonjic D; Gottfried M; Novello S; Reck M; Corral J; Grohé C; Popat S; Kaiser R;
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. in The Lancet. Oncology / Lancet Oncol. 2014 Feb;15(2):143-55. doi: 10.1016/S1470-2045(13)70586-2. Epub 2014 Jan 9.
2014
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S;